The Digest

Pharma news roundup and Larvol updates

Contact Us
Category: Company News

Larvol Veri Launch Party

June 3, 2020

Our amazing team at the Larvol Veri launch party yesterday.  It is a pleasure working with these talented people everyday and coming together as a team to celebrate our new launch.

 

Get started with Larvol Veri at larvolveri.com

 

Read More …

Larvol Launches AI-Powered Cancer Data Platform During ASCO 2020

June 1, 2020

SAN FRANCISCO–(BUSINESS WIRE)–The Larvol Group, a Software as a Service (SaaS) company with 125 employees, announced the launch of Veri, their new decision support and competitive intelligence tool during the 2020 ASCO Annual Meeting. The Veri platform offers access to a knowledgebase for predictive biomarkers in oncology and is free for non-commercial use.

 

“Veri is an extremely ambitious project and our focus is to move beyond the capabilities of existing knowledgebases by providing biomarker data that is relevant, up to date, and reviewed by a trusted team of experts. We’ve perfected pharma and biotech data curation for over 15 years, and we’re now carrying that forward in the biomarker space,” said Bruno Larvol, Founder & CEO.

 

Veri enables users to search for biomarkers and view associated drug responses, ordered by level of evidence (FDA approval to case studies). Users can also access biomarker related heatmaps, trials, and news. In addition, users receive tailored biomarker and companion diagnostic alerts. Co-developed in partnership with major US pharmaceutical companies, features include:

 

  • Extensive dataset includes broad coverage of predictive biomarkers in oncology
  • Intuitive search allows users to perform queries for biomarkers, products, mechanisms, genes, tests, and cancer types
  • Data updated in real-time with ability to flag items for review
  • Custom push alerts containing the latest biomarker and companion diagnostic news
  • Broad data sourcing from news, publications, clinical trial data, conference abstracts, and Twitter mentions from thought leaders
  • Advanced visualization and analytics of biomarker-drug relationships
  • Artificial intelligence applications to extrapolate emerging areas for investigation and enhanced data visualization are among additional releases planned throughout 2020

 

About Larvol:

 

Larvol provides SaaS solutions to support the needs of the pharmaceutical and biotech industry. Their products include secondary competitive intelligence, KOL tracking, and conference planning solutions. Larvol curates data using a proven combination of broad therapeutic-area expertise and proprietary natural language processing technology to keep their customers at the forefront of the industry. The 100% remote Larvol team includes MDs, PhDs, and industry professionals who curate data from over 25,000 sources and distill the most relevant information into concise reports that provide real-time insights and time-saving analysis.

 

For more information about Larvol Veri or sales inquiries, please contact us at veri@larvol.com.

 

Larvol
Sabrina Bellisario – sabrina.bellisario@larvol.com
+1 415.874.3310

Read More …

Top 15 NGS Panels for Cancer

April 10, 2020

“Lab directors ask themselves: how do I choose or create the best NGS panel for my laboratory? At the same time, clinical teams ask themselves: what is the best NGS panel to understand biology in a difficult case? Each expert team needs a panel, but what makes a panel suited to each lab is unique.”

 

Read the full article on Medium here: http://ow.ly/tQHF50zbd4A

 

Read More …

Larvol Omni – Video

July 26, 2019

Receive ongoing, comprehensive updates on KOL and drug activity; including publications, clinical trial involvement, social media, and upcoming event attendance (conferences, symposiums, grand rounds, CMEs).

 

Click here for more information.

 

Read More …

Larvol Launches Omni, Its Next Gen KOL and Pharma Tracking Tool

March 11, 2019

SAN FRANCISCO–(BUSINESS WIRE)–Larvol, a San Francisco-based pharma SaaS (Software as a Service) company, announced the launch of Omni, their newest Medical Communications and Competitive Intelligence tool at the Medical Affairs Professional Society Annual Conference in New Orleans, LA. The Omni platform, available on both desktop and mobile devices, offers users the ability to track developments related to Key Opinion Leaders, including conferences, social media, and clinical trials in real time.

 

“We were emboldened by the feedback we received from our customers to develop a dynamic platform that can be widely adopted by Med Comm and Med Affairs teams as well as CI pros who have been relying on our solutions in the pharma industry for more than a decade,” said CEO Dr. Aviva Fridman. “I am excited to get Omni into the hands of customers who will benefit from instant access to their market and KOL data.”

 

Omni enables users to choose their target KOLs and access their activity instantly via their desktop or mobile device. Features include:

    • Advanced KOL tracking: publications, upcoming events, clinical trials, Sunshine data, and social media relevant to specific KOLs
    • Ability to easily identify critical news, bookmark, and add notes for the KOLs you follow
    • A social experience: like, share, and comment on news items within organizations
    • Additional releases are planned throughout 2019 to enhance Omni functionality including analytics, individual news feeds for pharmaceutical products, diseases, drug pipelines, mechanisms of action, and conference planners

 

About Larvol:

 

Larvol provides SaaS solutions that support competitive intelligence, business intelligence, and medical communications departments in the pharmaceutical and biotech industry. Their products include secondary competitive intelligence reports, KOL tracking, and conference planning solutions. Larvol curates pharmaceutical and biotech competitive intelligence using a proven combination of broad therapeutic-area expertise and technological innovation to keep their customers at the forefront of the industry. The Larvol team consists of MDs and PhDs who curate data from over 25,000 sources and distill the most relevant findings into concise reports that provide real-time insights and time-saving analysis.

For more information about Larvol or sales inquiries, please contact us at info@larvol.com. New users can register at www.larvolomni.com.

 

Contacts
Larvol
Amanda Witte • amanda.witte@larvol.com

Read More …

The Larvol App – Video

June 11, 2018

The Larvol App offers users the ability to track new developments related to Key Opinion Leaders, pharmaceutical products, and clinical trials in real time. Access advanced KOL tracking for publications, upcoming events, clinical updates, and social media relevant to specific KOLs. You’ll find a social experience: like, share, and comment on news items within an organization. Also includes individual news feeds for pharmaceutical products, diseases, mechanisms of action, and clinical trials.

 

Read More …

Larvol Transforms Competitive Intelligence Space With Launch of KOL and Pharma Tracking Mobile App

February 27, 2018

SAN FRANCISCO–(BUSINESS WIRE)–Larvol, a San Francisco-based pharma SaaS (Software as a Service) company, announced today the launch of their iOS mobile app at the Pharma CI Europe Conference & Exhibition in Lisbon, Portugal. This new mobile experience offers users the ability to track new developments related to Key Opinion Leaders, pharmaceutical products, and clinical trials in real time on their smartphones.

 

“We have been providing comprehensive competitive intelligence solutions to the pharmaceutical industry for more than a decade, so it was a natural progression to move to a mobile platform,” said company founder Bruno Larvol. “I am excited to formally launch our app at Pharma CI. The timing is perfect – our industry is exploring the best ways to leverage technology for real time access to market insights.”

 

The Larvol mobile app enables users to customize an in-app dashboard according to their specific needs and interests in the pharmaceutical space. Its features include:

    • Advanced KOL tracking: publications, upcoming events, clinical updates, and social media relevant to specific KOLs
    • social experience: like, share, and comment on news items within an organization
    • Individual news feeds for pharmaceutical products, diseases, mechanisms of action, and clinical trials

 

About Larvol:

 

Larvol provides SaaS solutions that support competitive intelligence, business intelligence, and medical communications departments in the pharmaceutical and biotech industry. Their products include secondary competitive intelligence reports, KOL tracking, and conference planning solutions. Larvol curates pharmaceutical and biotech competitive intelligence using a proven combination of broad therapeutic-area expertise and technological innovation to keep their customers at the forefront of the industry. The Larvol team consists of MDs and PhDs who collate data from over 25,000 sources and distill the most relevant findings into concise reports that provide real-time insights and time-saving analysis.

 

For more information about Larvol or sales inquiries, please visit www.larvol.com or contact us at info@larvol.com. Download the app in the App Store.

 

Contacts
Larvol
Amanda Witte • amanda.witte@larvol.com

Read More …